- Trials with a EudraCT protocol (4)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
4 result(s) found for: Carotid artery dissection.
Displaying page 1 of 1.
EudraCT Number: 2015-003200-23 | Sponsor Protocol Number: 2013DR3084 | Start Date*: 2016-04-21 |
Sponsor Name:University Hospital Basel; Neurology | ||
Full Title: Biomarkers and antithrombotic treatment in cervical artery dissection (TREAT-CAD) | ||
Medical condition: cervical artery dissection | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: DE (Completed) DK (Completed) | ||
Trial results: View results |
EudraCT Number: 2022-002266-33 | Sponsor Protocol Number: SATURN | Start Date*: 2022-10-10 |
Sponsor Name:BETH ISRAEL DEACONESS MEDICAL CENTER | ||
Full Title: STATINS USE IN INTRACEREBRAL HEMORRHAGE PATIENTS (SATURN) | ||
Medical condition: Intracerebral Hemorrhage (ICH) recurrence | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2013-000768-27 | Sponsor Protocol Number: BAY59-7939/16573 | Start Date*: 2015-01-29 | |||||||||||
Sponsor Name:Bayer HealthCare AG | |||||||||||||
Full Title: Multicenter, randomized, double-blind, double-dummy, active-comparator, event-driven, superiority phase III study of secondary prevention of stroke and prevention of systemic embolism in patients w... | |||||||||||||
Medical condition: Embolic stroke of undetermined source (ESUS) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Completed) IE (Prematurely Ended) PT (Prematurely Ended) CZ (Completed) BE (Completed) ES (Completed) IT (Prematurely Ended) HU (Completed) FI (Prematurely Ended) DK (Prematurely Ended) GB (Prematurely Ended) AT (Prematurely Ended) GR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2021-002163-22 | Sponsor Protocol Number: NANORAY-312 | Start Date*: 2022-07-13 | |||||||||||
Sponsor Name:Nanobiotix SA | |||||||||||||
Full Title: A Phase 3 (Pivotal Stage) Study of NBTXR3 Activated by Investigator’s Choice of Radiotherapy Alone or Radiotherapy in Combination with Cetuximab for platinum-based Chemotherapy-ineligible Elderly P... | |||||||||||||
Medical condition: Locally Advanced Head & Neck Squamous Cell Carcinoma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Trial now transitioned) IT (Prematurely Ended) CZ (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
